Mount Vernon Associates’s GE HealthCare GEHC Stock Holding History

Mount Vernon Associates’s Portfolio GEHC Stock Details GEHC Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q3	$976K	Sell	14,924 -1,253	-8%	-$84.8K	0.65%	35
2026 Q2	$1.04M	Sell	16,177 -1,988	-11%	-$131K	0.67%	34
2026 Q1	$1.29M	Buy	18,165 +144	+0.8%	+$11.4K	0.91%	29
2025 Q4	$1.48M	Hold	18,021	–	–	0.99%	28
2025 Q3	$1.35M	Buy	18,021 +50	+0.3%	+$3.73K	0.94%	28
2025 Q2	$1.33M	Buy	17,971 +250	+1%	+$17.4K	0.96%	27
2025 Q1	$1.43M	Sell	17,721 -33	-0.2%	-$2.84K	1.17%	25
2024 Q4	$1.39M	Hold	17,754	–	–	1.08%	25
2024 Q3	$1.67M	Buy	17,754 +634	+4%	+$53.2K	1.32%	24
2024 Q2	$1.33M	Sell	17,120 -600	-3%	-$48.9K	1.18%	24
2024 Q1	$1.61M	Hold	17,720	–	–	1.37%	24
2023 Q4	$1.37M	Sell	17,720 -133	-0.7%	-$9.31K	1.34%	24
2023 Q3	$1.22M	Buy	17,853 +62	+0.3%	+$4.51K	1.34%	24
2023 Q2	$1.44M	Buy	17,791 +13,903	+358%	+$1.11M	1.54%	24
2023 Q1	$319K	Buy	+3,888	New	+$278K	0.38%	41

Other funds holding GEHC

Geode Capital Management Boston, Massachusetts $1.92T AUM 36.1% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $551B AUM 33.95% 1-Year Est. Return

LSV Asset Management Chicago, Illinois $54.1B AUM 39.29% 1-Year Est. Return

Amundi Paris, France $496B AUM 35.36% 1-Year Est. Return

Perpetual Ltd Sydney, New South Wales, Australia $6.57B AUM 14.15% 1-Year Est. Return

Bank of New York Mellon New York $608B AUM 32.77% 1-Year Est. Return

Barclays London, United Kingdom $500B AUM 36.84% 1-Year Est. Return

Deutsche Bank Frankfurt Am Main Ge, Germany $362B AUM 34.89% 1-Year Est. Return

Locust Wood Capital Advisers New York $4.43B AUM 19.95% 1-Year Est. Return

Pzena Investment Management New York $34.1B AUM 26.62% 1-Year Est. Return

Mount Vernon Associates's GEHC Position: Q3 2026 in Review

Mount Vernon Associates reduced its GE HealthCare (GEHC) stake by 7.7% in Q3 2026, selling an estimated $84.8K and leaving 14,924 shares worth $976K. The position accounts for 0.65% of the portfolio, ranked #35.

Mount Vernon Associates first reported a position in GEHC in Q1 2023 and has held it in 15 quarters since. The position peaked at $1.67M in Q3 2024. 657 funds tracked by Wall St. Rank hold GEHC as of Q3 2026.

Mount Vernon Associates held 14,924 shares of GE HealthCare worth $976K as of Q3 2026.
Mount Vernon Associates sold 1,253 GE HealthCare shares in Q3 2026, an estimated $84.8K.
GE HealthCare made up 0.65% of Mount Vernon Associates's portfolio in Q3 2026, its #35 holding.
Mount Vernon Associates first reported a position in GE HealthCare in Q1 2023 and has held it in 15 quarters since.
Mount Vernon Associates's GE HealthCare position peaked at $1.67M in Q3 2024.
657 funds tracked by Wall St. Rank held GE HealthCare as of Q3 2026.

Based on Mount Vernon Associates's 13F filing for Q3 2026, filed 26 Oct 2026.